SOURCE: Plandai Biotechnology, Inc.

Plandai Biotechnology, Inc.

May 10, 2016 07:00 ET

Plandai Biotechnology, Inc. Announces Vitamin Express to Release New Product Containing Phytofare®

LONDON, UNITED KINGDOM--(Marketwired - May 10, 2016) - Plandaí Biotechnology, Inc. (OTCQB: PLPL) ("Plandaí" or "the Company"), producer of the highly bioavailable Phytofare® catechin complex, today announced VitaminExpress, a highly successful health supplement company based in the European Union, is set to release a new product this month, with Phytofare® Catechin Complex as the main ingredient, which will be incorporated into their current product line. Vitamin Express has shipped an astounding 5 million products over the previous 20 years, with customers throughout Western and Eastern Europe.

VitaminExpress added the following statement, "After learning about the impressive bioavailability study results of Phytofare® we immediately decided to incorporate this unique Green Tea Extract into our line of high quality supplements. Our customers appreciate the fact that we are always searching the globe to find natural, effective ingredients for our products. Therefore we are truly thrilled to be able to offer the very best Green Tea Extract available with our new product Green Tea Royal, containing Phytofare®."

Callum Cottrell-Duffield, Vice President of Sales and Marketing for Plandaí, stated, "We are happy to have our product in the hands of such a great company and look forward to a long relationship. Adding Vitamin Express to our customer base increases our overall presence in the marketplace as more and more supplement manufacturers understand the need to deliver bioavailable ingredients to consumers. Phytofare® alone is clinically proven to provide the entire phytonutrient complex, which is then present in the bloodstream at therapeutic levels for an unprecedented 24 hours."

In discussing the company's sales strategy, Mr. Cottrell-Duffield added, "Thus far we have employed a dual approach, working directly with large customers when feasible while also cultivating relationships with both distributors and contract manufacturers. As a supplement ingredient, the potential applications and products are limitless, making our approach the best for capturing market share at an accelerated rate. Large manufacturers understandably have a long buy cycle as any new ingredient must first undergo rigorous in-house testing. Once a positive decision is made, the customer must then re-design packaging and obtain any necessary approvals. We've found that customers like to gauge consumer reaction before placing large orders, but every month our sales have continued to climb as new customers join us and existing customers re-order at larger quantities. With Phytofare® now fairly well entrenched in both Africa and Europe, we look to expand sales into North America and Australia in the coming months."

For more information about Vitamin Express, visit their website at https://www.vitaminexpress.org

About Plandaí Biotechnology, Inc.

Plandaí Biotechnology, Inc. and its subsidiaries develop highly phyto-available™ extracts. Plandaí Biotechnology controls every aspect of the process, from growing the raw materials on its farms in South Africa, to producing its proprietary Phytofare® extracts in-house, allowing the Company to guarantee the continuity of supply as well as quality control throughout the entire process. Targeted industries for the Company's products include beverage, cosmeceutical, wellness, nutriceutical, anti-aging, and pharmaceutical. For more information, please visit http://www.plandaibiotech.com.

Safe Harbor Statement

This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance or guarantee that such expectations and assumptions will prove to have been correct. Forward-looking statements are generally identifiable by the use of words like "may," "will," "should," "could," "expect," "anticipate," "estimate," "believe," "intend," or "project" or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including but not limited to: adverse economic conditions, competition, adverse federal, state and local government regulation, international governmental regulation, inadequate capital, inability to carry out research, development and commercialization plans, loss or retirement of key executives and other specific risks. To the extent that statements in this press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made. Readers are advised to review our filings with the Securities and Exchange Commission that can be accessed over the Internet at the SEC's website located at http://www.sec.gov.

Contact Information

  • Contact:
    Hannah Merrill
    (917) 900-9829